Clinical Trial

Total Knee Replacement with Tourniquet or Aquamantys

Study Description

Total Knee Replacement With Tourniquet or Aquamantys

The purpose of this study is to compare quadriceps muscle strength, pain, opioid consumption and patient function during the first three months after short-stay total knee replacement between patients treated with short-duration tourniquet knee replacement with the AquamantysAR bipolar sealer versus those treated with the standard of care (tourniquet used throughout the case and no AquamantysAR). By doing this study, investigators hope to learn if short duration tourniquet knee replacement with the AquamantysAR bipolar sealer is more effective than standard of care (tourniquet used throughout the case and no AquamantysAR). The purpose of this study is to compare quadriceps muscle strength, pain, opioid consumption and patient function during the first three months after short-stay total knee replacement between patients treated with short-duration tourniquet knee replacement with the AquamantysAR bipolar sealer versus those treated with the standard of care (tourniquet used throughout the case and no AquamantysAR).

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - Aquamantys

The Aquamantys bipolar sealer is a device used during surgery to help reduce bleeding in the joint. The system uses radiofrequency energy and sterile saline (salt water) to close small blood vessels in the knee to help reduce bleeding.

Device - Tourniquet

Standard of care for reducing bleeding during the total knee arthroplasty

Additional Information

Official Study Title

Comparison to Short-duration Tourniquet Total Knee Arthroplasty (TKA) With the Aquamantys® Bipolar Sealer and the Standard of Care in the Setting of Outpatient TKA: A Randomized, Double-blinded Study

Clinical Trial ID

NCT04016285

ParticipAid ID

av2M5a